glp-1 pill news FDA approves first for weight loss FDA approves first weight-loss GLP-1

Short-acting preparations include beinaglutide (BN) and exenatide (EX), which generally need to be injected 2-3 times a day

Retatrutide is not a controlled substance under the Misuse of Drugs Act 1971 or the Psychoactive Substances Act 2016 as of 2026

For example: Mars acquisition of Kevins Natural Foods gives the company access to a portfolio of high-protein, low-carb meals and snacks Kepaks purchase of King West Pack strengthens its position in the high-protein, on-the-go snacking sector, expanding its reach across the UK and international markets Ferreros acquisition of protein snack maker Power Crunch reflects a move away from indulgent treats, giving the company a Better-for-You snack brand The Opportunity Ahead As GLP-1s continue to shape consumer eating habits, emerging brands and mid-sized players in hot categories will make for attractive acquisition targets

Contains glutathione, a powerful antioxidant for skin lightening and brightening

Carbapenems irreversibly inhibits acylpeptide hydrolase, thereby reducing enterohepatic circulation of valproate